CoChat

Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology

Open access
Romero-Molina, Carmen, Navarro, Victoria, Sanchez-Varo, Raquel, Jimenez, Sebastian, Fernandez-Valenzuela, Juan J., Sanchez-Mico, Maria V., Muñoz-Castro, Clara, Gutierrez, Antonia, Vitorica, Javier, Vizuete, Marisa · 2018 · Frontiers in Cellular Neuroscience
Cited by 27

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Microglial cells are crucial players in the pathological process of neurodegenerative diseases, such as Alzheimer´s disease (AD). Microglial response in AD has been principally studied in relation to amyloid-beta pathology but, comparatively, little is known about inflammatory processes associated to tau pathology. In the hippocampus of AD patients, where tau pathology is more prominent than amyloid-beta pathology, a microglial degenerative process has been reported. In this work, we have directly compared the microglial response in two different transgenic tau mouse models: ThyTau22 and P301S. Surprisingly, these two models showed important differences in the microglial profile and tau pathology. Where ThyTau22 hippocampus manifested mild microglial activation, P301S mice exhibited a strong microglial response in parallel with high phospho-tau accumulation. This differential phospho-tau expression could account for the different microglial response in these two tau strains. However, soluble (S1) fractions from ThyTau22 hippocampus presented relatively high content of soluble phospho-tau (AT8-positive) and were highly toxic for microglial cells in vitro, whereas the correspondent S1 fractions from P301S mice displayed low soluble phospho-tau levels and were not toxic for microglial cells. Therefore, not only the expression levels but the aggregation of phospho-tau should differ between both models. In fact, most of tau forms in the P301S mice were aggregated and, in consequence, forming insoluble tau species. We conclude that different factors as tau mutations, accumulation, phosphorylation and/or aggregation could account for the distinct microglial responses observed in these two tau models. For this reason, deciphering the molecular nature of toxic tau species for microglial cells might be a promising therapeutic approach in order to restore the deficient immunological protection observed in AD hippocampus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fncel.2018.00421

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 27

Metadata

Authors
Romero-Molina, C., Navarro, V., Sanchez-Varo, R., Jimenez, S., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Muñoz-Castro, C., Gutierrez, A., Vitorica, J., & Vizuete, M.
Venue
Frontiers in Cellular Neuroscience
Published
2018-11-14
Volume
12
Pages
421-421
ISSN
1662-5102 (ISSN-L)
OpenAlex
W2900928998
Cited by
27
References
48
FWCI
2.38
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology. https://app.cochat.ai/papers/10.3389/fncel.2018.00421
The paper
Romero-Molina, C., Navarro, V., Sanchez-Varo, R., Jimenez, S., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Muñoz-Castro, C., Gutierrez, A., Vitorica, J., & Vizuete, M. (2018). Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2018.00421

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.